NHS Introduces One-Minute Injectable Immunotherapy for Cancer Patients

In Brief

The new injection aims to reduce hospital time and ease the workload for NHS staff treating cancer patients.

Key Facts

• Thousands of NHS cancer patients will be offered a new injectable form of an immunotherapy drug.
• The injection takes only minutes to administer, compared to traditional intravenous infusions.
• Current intravenous preparations require hospital pharmacy teams to prepare the drug in sterile conditions.
• The new method could mean patients spend hours less in hospital for treatment.
• Tens of thousands could benefit from the rollout, according to reports.

What Happened

A new injectable form of an immunotherapy drug is being rolled out on the NHS, allowing cancer patients to receive treatment in minutes rather than hours.

Why It Matters

This change is expected to reduce the time patients spend in hospitals and lessen the workload for NHS staff involved in drug preparation and administration.

What's Next

Eligible patients will begin receiving the new injection as part of their cancer treatment. Further updates on patient outcomes and NHS efficiency may follow.